Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

Signal-detection algorithms (SDAs) are recognized as vital tools in pharmacovigilance. However, their performance characteristics are generally unknown. By leveraging a unique gold standard recently made public by the Observational Medical Outcomes Partnership (OMOP) and by conducting a unique syste...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics Vol. 93; no. 6; p. 539
Main Authors: Harpaz, R, DuMouchel, W, LePendu, P, Bauer-Mehren, A, Ryan, P, Shah, N H
Format: Journal Article
Language:English
Published: United States 01.06.2013
Subjects:
ISSN:1532-6535, 1532-6535
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first